Evotec Investor Presentation Deck

evotec Global precision medicine market¹) in US$ bn Global cell therapy market²) in US$ bn Global induced pluripotent stem cell (iPSC) Market in US$ bn PAGE 18 63 2020 7.8 2020 1.6 2020 Transformative iPSC-based disease modelling & cell therapy Industry leading iPSC platform 107 2025 15.7 2025 2.3 2025 CAGR ~11% CAGR ~15% CAGR ~7% "IPS cells are a powerful tool to cure intractable diseases because they can be made from patients' somatic cells." Shinya Yamanaka, Nobel prize laureate DRUG DISCOVERY Disease-specific drugs "Disease in a dish" & Screening Patient or healthy donor iPSC platform ¹) https://www.gminsights.com/ Feb 2020, Evotec estimates 2) https://www.grandviewresearch.com/industry-analysis/cell-therapy-market, Evotec estimates https://www.researchandmarkets.com/reports/4805485/induced-pluripotent-stem-cell-ipsc-global CELL THERAPY ¡PSC-derived cell types 000 ooo AAS Off-the-shelf cell therapeutic "Evotec's iPSC platform with the goal to industrialise iPSC- based drug screening" Largest and most sophisticated iPSC platform in the industry >300 patient-derived cell lines across 15+ disease areas Optimized for high reproducibility, high throughput and robustness First IPSC-derived drug candidate entered clinical trials in 2021

View entire presentation